Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies.

Kwatra SG, Ständer S, Kim BS, Msihid J, Bansal A, Makhija M, Wiggins S, Zahn J, Thomas RB, Bahloul D

Open source

DOI
10.1007/s13555-026-01674-5
Published
2026 Mar
Container
Dermatology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01674-5,
  title = {Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies.},
  author = {Kwatra SG and Ständer S and Kim BS and Msihid J and Bansal A and Makhija M and Wiggins S and Zahn J and Thomas RB and Bahloul D},
  year = {2026},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-026-01674-5},
  url = {https://doi.org/10.1007/s13555-026-01674-5}
}

RIS

TY  - JOUR
TI  - Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies.
AU  - Kwatra SG
AU  - Ständer S
AU  - Kim BS
AU  - Msihid J
AU  - Bansal A
AU  - Makhija M
AU  - Wiggins S
AU  - Zahn J
AU  - Thomas RB
AU  - Bahloul D
PY  - 2026
JO  - Dermatology and therapy
DO  - 10.1007/s13555-026-01674-5
UR  - https://doi.org/10.1007/s13555-026-01674-5
ER  - 

APA

SG, K., S, S., BS, K., J, M., A, B., M, M., S, W., J, Z., RB, T., & D, B. (2026). Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01674-5

Source records